Menu Search
Equities

Tissue Regenix Group PLC

LSW:BER

Tissue Regenix Group PLC

Actions
  • Price (EUR)0.705
  • Today's Change0.000 / 0.00%
  • Shares traded--
  • 1 Year change+15.57%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 07:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Tissue Regenix Group PLC grew revenues 20.50% from 24.48m to 29.49m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -2.70m to -1.71m.
Gross margin49.48%
Net profit margin-3.08%
Operating margin1.14%
Return on assets-2.17%
Return on equity-3.63%
Return on investment-2.43%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Tissue Regenix Group PLC fell by 1.30m. However, the company earned 1.04m from its operations for a Cash Flow Margin of 3.53%. In addition the company used 837.00k on investing activities and also paid 1.51m in financing cash flows.
Cash flow per share0.0004
Price/Cash flow per share1,499.08
Book value per share0.3301
Tangible book value per share0.163
More ▼

Balance sheet in USDView more

Tissue Regenix Group PLC has a Debt to Total Capital ratio of 26.30%, a lower figure than the previous year's 29.70%.
Current ratio3.74
Quick ratio1.47
Total debt/total equity0.3486
Total debt/total capital0.263
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.